问卷报告听力与医疗记录验证:瑞士儿童癌症幸存者研究报告

基于瑞士儿童癌症幸存者研究的361例患者数据,验证问卷报告听力与医疗记录的一致性及有效性。

Figshare
2017-03-24 更新
浏览 18
表格childhood cancerquestionnaire-reported hearingSCCSSSIOP Boston Ototoxicity Scalehearing lossResults Questionnaire reportsototoxic cancer treatmentchildhood cancer survivorsSwiss Childhood Cancer Survivor Study
Validation of questionnaire-reported hearing with medical records: A report from the Swiss Childhood Cancer Survivor Study

基本信息

模态
表格
大小
0.001438058 GB
许可
CC BY 4.0
创建/更新时间
2017-03-24
版本
v1

资源简介

问卷报告听力与医疗记录验证:瑞士儿童癌症幸存者研究报告

【数据集背景】

本数据集源站标题为《Validation of questionnaire-reported hearing with medical records: A report from the Swiss Childhood Cancer Survivor Study》。配套论文《Validation of questionnaire-reported hearing with medical records: A report from the Swiss Childhood Cancer Survivor Study》发表于 PLOS ONE(2017),DOI:10.1371/journal.pone.0174479。源站首次发布:2017-03-23。

【数据内容】

源站原始描述:Background Hearing loss is a potential late effect after childhood cancer. Questionnaires are often used to assess hearing in large cohorts of childhood cancer survivors and it is important to know if they can provide valid measures of hearing loss. We therefore assessed agreement and validity of questionnaire-reported hearing in childhood cancer survivors using medical records as reference. Procedure In this validation study, we studied 361 survivors of childhood cancer from the Swiss Childhood…

【数据结构与技术规格】

文件数 5 个,合计 1.44 MB。S1 Fig.tif:image/tiff,13.00 KB。S2 Fig.tif:image/tiff,583.41 KB。S3 Fig.tif:image/tiff,619.59 KB。数据集 DOI:10.1371/journal.pone.0174479。

【主题与分类】

源站学科分类:Biophysics、Medicine、Cell Biology、Genetics、Molecular Biology、Neuroscience。主题标签:childhood cancer、questionnaire-reported hearing、SCCSS、SIOP Boston Ototoxicity Scale、Swiss Childhood Cancer Survivor Study Background Hearing loss、hearing loss、Results Questionnaire reports、ototoxic cancer treatment、childhood cancer survivors、Swiss Childhood Cancer Survivor Study。

【适用方向】

结构化表格数据可直接用于统计建模、特征工程与队列分析。

【获取与许可】

源站页面:https://plos.figshare.com/articles/dataset/Validation_of_questionnaire-reported_hearing_with_medical_records_A_report_from_the_Swiss_Childhood_Cancer_Survivor_Study/4783825

使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。

规范引用:Weiss, Annette; Sommer, Grit; Kuonen, Rahel; Scheinemann, Katrin; Grotzer, Michael; Kompis, Martin; et al. (2017). Validation of questionnaire-reported hearing with medical records: A report from the Swiss Childhood Cancer Survivor Study. PLOS ONE. Dataset

【使用注意】

· 源站最后修改于 2023-06-07,引用时请注意版本时效。

官方服务

专家保障全链路合规授权与标注交付

陕川双基地 × 超十家三甲医院直连

从合规授权、采集治理、专业标注到数据集交付,我们提供全链路闭环服务,让高质量临床数据即拿即用。

⚡️ 需要原始数据或标注支持?联系我们获取定制方案。

帮我联系

下载信息

注册下载

需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。

暂未开放

公开下载

无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。

免登录

有偿下载

公开数据集受托下载与技术交付服务。

提供高速下载与技术交付服务(收技术服务费,非数据销售)

暂未开放

当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。

使用方式

数据集获取(Figshare)

命令行下载

curl -L -o "S1 Fig.tif" "https://ndownloader.figshare.com/files/7867255"
curl -L -o "S2 Fig.tif" "https://ndownloader.figshare.com/files/7867282"
curl -L -o "S3 Fig.tif" "https://ndownloader.figshare.com/files/7867300"
curl -L -o "S1 Table.pdf" "https://ndownloader.figshare.com/files/7867321"
curl -L -o "S2 Table.pdf" "https://ndownloader.figshare.com/files/7867339"

文件清单

  • S1 Fig.tif(13.00 KB)
  • S2 Fig.tif(583.41 KB)
  • S3 Fig.tif(619.59 KB)
  • S1 Table.pdf(185.35 KB)
  • S2 Table.pdf(36.71 KB)

文件总体积 1.44 MB(源站 API 实测)。

数据加载示例(图像类)

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Background
Hearing loss is a potential late effect after childhood cancer. Questionnaires are often used to assess hearing in large cohorts of childhood cancer survivors and it is important to know if they can provide valid measures of hearing loss. We therefore assessed agreement and validity of questionnaire-reported hearing in childhood cancer survivors using medical records as reference.
Procedure
In this validation study, we studied 361 survivors of childhood cancer from the Swiss Childhood Cancer Survivor Study (SCCSS) who had been diagnosed after 1989 and had been exposed to ototoxic cancer treatment. Questionnaire-reported hearing was compared to the information in medical records. Hearing loss was defined as ≥ grade 1 according to the SIOP Boston Ototoxicity Scale. We assessed agreement and validity of questionnaire-reported hearing overall and stratified by questionnaire respondents (survivor or parent), sociodemographic characteristics, time between follow-up and questionnaire and severity of hearing loss.
Results
Questionnaire reports agreed with medical records in 85% of respondents (kappa 0.62), normal hearing was correctly assessed in 92% of those with normal hearing (n = 249), and hearing loss was correctly assessed in 69% of those with hearing loss (n = 112). Sensitivity of the questionnaires was 92%, 74%, and 39% for assessment of severe, moderate and mild bilateral hearing loss; and 50%, 33% and 10% for severe, moderate and mild unilateral hearing loss, respectively. Results did not differ by sociodemographic characteristics of the respondents, and survivor- and parent-reports were equally valid.
Conclusions
Questionnaires are a useful tool to assess hearing in large cohorts of childhood cancer survivors, but underestimate mild and unilateral hearing loss. Further research should investigate whether the addition of questions with higher sensitivity for mild degrees of hearing loss could improve the results.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.1371/journal.pone.0174479(source: https://plos.figshare.com/articles/dataset/Validation_of_questionnaire-reported_hearing_with_medical_records_A_report_from_the_Swiss_Childhood_Cancer_Survivor_Study/4783825)。

数据缺失?

依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。

⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。

获取专属数据定制方案